Therapeutic Agents for Alzheimer's Disease

E-ISSN： 1875-6158|5|4|259-269

ISSN： 1568-0150

Source： Current Medicinal Chemistry - Central Nervous System Agents, Vol.5, Iss.4, 2005-01, pp. : 259-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential in Alzheimer Disease

Current Medicinal Chemistry, Vol. 9, Iss. 17, 2002-09 ,pp. : 1605-1610

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 27, 2017-11 ,pp. : 3000-3016

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 13, 2015-09 ,pp. : 1110-1121

Bentham Science Publishers

Access to resources Recommend Favorite

Gelsolin as therapeutic target in Alzheimer's disease

By Carro Eva

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. : 585-592

Informa Healthcare

Access to resources Recommend Favorite

The “Aged Garlic Extract” (AGE) and One of its Active Ingredients S-Allyl-LCysteine (SAC) as Potential Preventive and Therapeutic Agents for Alzheimer's Disease (AD)

Current Medicinal Chemistry, Vol. 18, Iss. 22, 2011-08 ,pp. : 3306-3313

Bentham Science Publishers

Access to resources Recommend Favorite